Clinical Trial Update: Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial [NA]

View source ↗

Summary

A multicenter, open-label trial evaluating whether adding cofrogliptin to baseline therapy is more effective and safe than escalating metformin dose in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cofrogliptin (Cofrogliptin)
• metformin (metformin)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Type 2 Diabetes | NA | Status: RECRUITING